Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2005; 11(46): 7261-7265
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7261
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7261
Figure 1 A: CAPAP concentration in serum within 24 h of hospital admission in patients with acute pancreatitis and in extrapancreatic controls.
Data as median and interquartile range (AP, acute pancreatitis; NPAP, non-pancreatic abdominal pain); B: CAPAP concentration in urine within 24 h of hospital admission in patients with acute pancreatitis and in extrapancreatic controls. Data as median and interquartile range (AP: acute pancreatitis; NPAP, non-pancreatic abdominal pain); C: Urinary TAP levels within 24 h of hospital admission in patients with acute pancreatitis and in extrapancreatic controls. Data as median and interquartile range (AP: acute pancreatitis; NPAP, non-pancreatic abdominal pain).
- Citation: Sáez J, Martínez J, Trigo C, Sánchez-Payá J, Compañy L, Laveda R, Griñó P, García C, Pérez-Mateo M. Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis. World J Gastroenterol 2005; 11(46): 7261-7265
- URL: https://www.wjgnet.com/1007-9327/full/v11/i46/7261.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i46.7261